Park Kyung Sun, Shin Jung-Ho, Jang Hye Ryoun, Lee Jung Eun, Huh Woo Seong, Kim Yoon Goo, Oh Ha Young, Kim Dae Joong
Division of Nephrology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Clin Transplant. 2014 Sep;28(9):953-60. doi: 10.1111/ctr.12388. Epub 2014 Jul 16.
Living-unrelated donors (LURD) have been widely used for kidney transplantation (KT). We retrospectively reviewed 779 patients who underwent living-donor KT from 2000 to 2012, to compare outcomes of 264 KT from LURD and 515 from living-related donors (LRD), and to identify risk factors for living KT. Median follow-up was 67 months. Mean donor age, total human leukocyte antigen (HLA) mismatches, and HLA-DR mismatches were higher, and mean estimated glomerular filtration rate (eGFR) was lower in LURD. Acute rejection (AR)-free survival (p = 0.018) and graft survival (p = 0.025) were lower for LURD than LRD, whereas patient survival rate was comparable. Cox regression analysis showed HLA-DR mismatches (OR 1.75 for one mismatch; OR 2.19 for two mismatches), recipient age ≤ 42 yr, and donor age > 50 yr were significant risk factors for acute rejection. For graft survival, AR and donor eGFR (OR 1.90, p = 0.035) were significant. We also identified significant impact of recipient age > 50 yr and diabetes for patient survival. However, KT from LURD was not a significant risk factor for AR (p = 0.368), graft survival (p = 0.205), and patient survival (p = 0.836). Our data suggest that donor eGFR and donor age are independent risk factors for clinical outcomes of living KT, which can be related with poor outcome of KT from LURD.
非亲属活体供者(LURD)已广泛应用于肾移植(KT)。我们回顾性分析了2000年至2012年期间接受活体供肾肾移植的779例患者,比较了264例来自非亲属活体供者的肾移植和515例来自亲属活体供者(LRD)的肾移植的结果,并确定了活体肾移植的危险因素。中位随访时间为67个月。非亲属活体供者的供者平均年龄、人类白细胞抗原(HLA)错配总数和HLA-DR错配数更高,而估计肾小球滤过率(eGFR)更低。非亲属活体供者的无急性排斥反应(AR)生存率(p = 0.018)和移植肾生存率(p = 0.025)低于亲属活体供者,而患者生存率相当。Cox回归分析显示,HLA-DR错配(1个错配的OR为1.75;2个错配的OR为2.19)、受者年龄≤42岁和供者年龄>50岁是急性排斥反应的显著危险因素。对于移植肾生存,急性排斥反应和供者eGFR(OR 1.90,p = 0.035)具有显著性。我们还确定了受者年龄>50岁和糖尿病对患者生存有显著影响。然而,非亲属活体供者的肾移植对于急性排斥反应(p = 0.368)、移植肾生存(p = 0.205)和患者生存(p = 0.836)而言并非显著危险因素。我们的数据表明,供者eGFR和供者年龄是活体肾移植临床结果的独立危险因素,这可能与非亲属活体供者肾移植的不良结局有关。